Federica Frezzato
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Outcomes of patients with CLL and borderline IGHV mutational status: a systematic review and meta analysis.
Journal: Biomarker research
Published: January 13, 2026
Circular RNA signature of aggressive CLL with t(14;19)(q32;q13). An ERIC study.
Journal: Journal of hematology & oncology
Published: April 15, 2025
Serum soluble interleukin-2 receptor levels in hairy cell leukaemia as a marker of tumour burden with prognostic value and as a tool for disease monitoring.
Journal: British journal of haematology
Published: March 05, 2025
Focal adhesion kinase as a new player in the biology of onco-hematological diseases: the starting evidence.
Journal: Frontiers in oncology
Published: June 11, 2024
Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax-based regimens.
Journal: British journal of haematology
Published: March 17, 2024
Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy.
Journal: Frontiers in immunology
Published: February 29, 2024
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course.
Journal: Cancers
Published: January 24, 2024
How receptor tyrosine kinase-like orphan receptor 1 meets its partners in chronic lymphocytic leukemia.
Journal: Hematological oncology
Published: October 12, 2023
p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation.
Journal: Frontiers in cell and developmental biology
Published: September 19, 2023
Last Updated: 09/26/2026